Current Report Filing (8-k)

Date : 05/15/2019 @ 9:29PM
Source : Edgar (US Regulatory)
Stock : Inspiremd Inc. (NSPR)
Quote : 3.23  -0.109 (-3.26%) @ 11:00PM

Current Report Filing (8-k)

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

 

 

Date of Report (Date of earliest event reported): May 15, 2019

 

InspireMD, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   001-35731   26-2123838
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

4 Menorat Hamaor St.

Tel Aviv, Israel

 

6744832

(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (888) 776-6804

 

 

 

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
[  ] Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered

Common Stock, par value $0.0001

per share

  NSPR   NYSE American

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company [  ]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

 

 

 

     
 

 

Item 8.01 Other Events.

 

On May 14, 2019, InspireMD, Inc. (the “Company”) announced its Stockholders’ Equity as of March 31, 2019. The Company is announcing today its pro forma Stockholders’ Equity as of March 31, 2019, which incorporates the closing of the Company’s underwritten public offering of 486,957 shares of its common stock at a price to the public of $5.00 per share on April 8, 2019, the closing of the exercise of the underwriter’s over-allotment option to purchase an additional 12,393 shares of its common stock at a price to the public of $5.00 per share (collectively, the “Public Offering”), and the estimated net loss for the month of April 2019 as of April 30, 2019 (the “Estimated April Net Loss”). After adjusting for the Public Offering and Estimated April Net Loss, as of April 30, 2019, the Company is pleased to announce Stockholders’ Equity of approximately $7.0 million on a pro forma basis, as of March 31, 2019.

 

Pro-forma Stockholders’ Equity

 

The following table sets forth the Company’s Stockholders’ Equity position as of March 31, 2019, as adjusted on a pro forma basis to reflect the Public Offering and Estimated April Net Loss as of April 30, 2019:

 

InspireMD, INC.

Pro Forma Stockholder’s Equity

(U.S. dollars in thousands)

(Unaudited)

 

Balance at March 31, 2019     5,640  
         
Proceeds from the Public Offering, net (1)     2,029  
Estimated April Net Loss (1) (2)     (671 )
Pro forma equity, as of March 31, 2019, as adjusted (1)     6,998  

 

(1) Not reviewed by independent auditors

 

(2) Net Loss net of Share Based Compensation as of April 30, 2019

 

     
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  InspireMD, Inc.
     
Date: May 15, 2019 By: /s/ Craig Shore
  Name: Craig Shore
  Title: Chief Financial Officer

 

     
 

Inspiremd Inc. (AMEX:NSPR)
Historical Stock Chart

1 Year : From Jul 2018 to Jul 2019

Click Here for more Inspiremd Inc. Charts.

Inspiremd Inc. (AMEX:NSPR)
Intraday Stock Chart

Today : Tuesday 16 July 2019

Click Here for more Inspiremd Inc. Charts.

Latest NSPR Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.